Sophiris Bio, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2013. For the quarter, the company reported revenue of $2,034,542 compared to $5,047,564 a year ago. Net loss before income tax expense was $2,636,030 compared to $5,688,478 a year ago. Net loss was $2,636,030 or $0.02 per basic and diluted share compared to $5,688,478 or $0.03 per basic and diluted share a year ago.

For six months, the company reported revenue of $5,776,456 compared to $9,144,563 a year ago. Net loss before income tax expense was $2,247,371 compared to $10,217,488 a year ago. Net loss was $2,747,371 or $0.02 per basic and diluted share compared to $10,217,488 or $0.07 per basic and diluted share a year ago. Net cash flows used in operating activities was of $1,636,433 compared to $8,584,530 a year ago. Purchase of property and equipment was of $2,742 compared to $20,718 a year ago.